Endovanilloids - Putative endogenous ligands of transient receptor potential vanilloid 1 channels

被引:315
作者
van der Stelt, M [1 ]
Di Marzo, V [1 ]
机构
[1] CNR, Ist Chim Biomol, Endocannabinoid Res Grp, I-80078 Pozzuoli, NA, Italy
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2004年 / 271卷 / 10期
关键词
anandamide; arachidonic acid; cannabinoid; lipid; signaling; TRP; VR1;
D O I
10.1111/j.1432-1033.2004.04081.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endovanilloids are defined as endogenous ligands of the transient receptor potential vanilloid type 1 (TRPV1) protein, a nonselective cation channel that belongs to the large family of TRP ion channels, and is activated by the pungent ingredient of hot chilli peppers, capsaicin. TRPV1 is expressed in some nociceptor efferent neurons, where it acts as a molecular sensor of noxious heat and low pH. However, the presence of these channels in various regions of the central nervous system, where they are not likely to be targeted by these noxious stimuli, suggests the existence of endovanilloids. Three different classes of endogenous lipids have been found recently that can activate TRPV1, i.e. unsaturated N-acyldopamines, lipoxygenase products of arachidonic acid and the endocannabinoid anandamide with some of its congeners. To classify a molecule as an endovanilloid, the compound should be formed or released in an activity-dependent manner in sufficient amounts to evoke a TRPV1-mediated response by direct activation of the channel. To control TRPV1 signaling, endovanilloids should be inactivated within a short time-span. In this review, we will discuss, for each of the proposed endogenous ligands of TRPV1, their ability to act as endovanilloids in light of the criteria mentioned above.
引用
收藏
页码:1827 / 1834
页数:8
相关论文
共 80 条
[41]   Activation of bronchopulmonary vagal afferent nerves with bradykinin, acid and vanilloid receptor agonists in wild-type and TRPV1-/- mice [J].
Kollarik, M ;
Undem, BJ .
JOURNAL OF PHYSIOLOGY-LONDON, 2004, 555 (01) :115-123
[42]   Oxidative metabolism of endocannabinoids [J].
Kozak, KR ;
Marnett, LJ .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2002, 66 (2-3) :211-220
[43]   Mammalian arachidonate 15-lipoxygenases - Structure, function, and biological implications [J].
Kuhn, H ;
Walther, M ;
Kuban, RJ .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2002, 68-9 :263-290
[44]   Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease [J].
Lastres-Becker, I ;
de Miguel, R ;
De Petrocellis, L ;
Makriyannis, A ;
Di Marzo, V ;
Fernández-Ruiz, J .
JOURNAL OF NEUROCHEMISTRY, 2003, 84 (05) :1097-1109
[45]   Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease [J].
Lastres-Becker, I ;
Hansen, HH ;
Berrendero, F ;
De Miguel, R ;
Pérez-Rosado, A ;
Manzanares, J ;
Ramos, JA ;
Fernández-Ruiz, J .
SYNAPSE, 2002, 44 (01) :23-35
[46]   Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake:: Comparison with effects on fatty acid amidohydrolase [J].
López-Rodríguez, ML ;
Viso, A ;
Ortega-Gutiérrez, S ;
Fowler, CJ ;
Tiger, G ;
de Lago, E ;
Fernández-Ruiz, J ;
Ramos, JA .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (08) :1512-1522
[47]   Anandamide hydrolysis by human cells in culture and brain [J].
Maccarrone, M ;
van der Stelt, M ;
Rossi, A ;
Veldink, GA ;
Vliegenthart, JFG ;
Agriò, AF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) :32332-32339
[48]  
Marinelli S, 2003, J NEUROSCI, V23, P3136
[49]   CB1 cannabinoid receptors and on-demand defense against excitotoxicity [J].
Marsicano, G ;
Goodenough, S ;
Monory, K ;
Hermann, H ;
Eder, M ;
Cannich, A ;
Azad, SC ;
Cascio, MG ;
Gutiérrez, SO ;
van der Stelt, M ;
López-Rodríguez, ML ;
Casanova, E ;
Schütz, G ;
Zieglgänsberger, W ;
Di Marzo, V ;
Behl, C ;
Lutz, B .
SCIENCE, 2003, 302 (5642) :84-88
[50]   Protease-activated receptor-2 activation causes EDHF-like coronary vasodilation - Selective preservation in ischemia/reperfusion injury: Involvement of lipoxygenase products, VR1 receptors, and C-fibers [J].
McLean, PG ;
Aston, D ;
Sarkar, D ;
Ahluwalia, A .
CIRCULATION RESEARCH, 2002, 90 (04) :465-472